Colistimethate
- Generic Name
- Colistimethate
- Brand Names
- Colobreathe, Coly Mycin M, Xylistin
- Drug Type
- Small Molecule
- Chemical Formula
- C58H105N16O28S5
- CAS Number
- 12705-41-8
- Unique Ingredient Identifier
- DL2R53P963
Overview
Colistimethate is an antibiotic that has been shown to have bactericidal activity against aerobic gram-negative microorganisms. Colistimethate is particularly indicated when the infection is caused by sensitive strains of Pseudomonas aeruginosa.
Background
Colistimethate is an antibiotic that has been shown to have bactericidal activity against aerobic gram-negative microorganisms. Colistimethate is particularly indicated when the infection is caused by sensitive strains of Pseudomonas aeruginosa.
Indication
For the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli, particularly Pseudomonas aeruginosa.
Associated Conditions
- Bacterial Infections
Clinical Trials
FDA Approved Products
Colistimethate
Manufacturer:XGen Pharmaceuticals DJB, Inc.
Route:INTRAMUSCULAR, INTRAVENOUS
Strength:150 mg in 2 mL
Approved: 2022/12/02
NDC:39822-0615
Colistimethate
Manufacturer:Fresenius Kabi USA, LLC
Route:INTRAMUSCULAR, INTRAVENOUS
Strength:150 mg in 2 mL
Approved: 2020/01/23
NDC:63323-393
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath